A clinical risk management plan should be reviewed at least yearly and also after major change, serious incidents, audit gaps, or new rules.

In healthcare, risk assessments should be reviewed at least yearly and sooner after incidents, changes, new hazards, or at each care transition.

Antidepressant treatment is best reviewed 2–4 weeks after start (1 week if risk), then more often early on and at wider gaps once stable.

HRT should be reviewed 3 months after starting or a change, then yearly, sooner if symptoms, side effects, or risks shift.

Healthcare SOPs should be reviewed every 1–3 years, and updated after rule changes, audits, incidents, or process changes.

Hospital policies and procedures should be reviewed at least once a year, faster for high-risk topics and whenever rules or practice change.

Review capacity assessments when decisions, health, risk, or communication change, and set planned checks for fluctuating or progressive conditions.

Health and safety policy in healthcare should be reviewed at least yearly and whenever laws, services, or risks change.

A diabetes care plan should be reviewed at least twice a year and any time goals, health, or life circumstances change.

An IFSP is reviewed at least every six months and evaluated yearly; extra reviews can happen anytime at the family’s request.